about
Drug transport in brain via the cerebrospinal fluidThe blood-brain barrier: bottleneck in brain drug developmentSelective expression of the large neutral amino acid transporter at the blood-brain barrierhnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivoReengineering biopharmaceuticals for targeted delivery across the blood-brain barrierBlood-brain barrier transcytosis of insulin in developing rabbitsDrug targeting to the brainCloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2.Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234.Blood-brain barrier genomics and cloning of a novel organic anion transporter.Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier.Rat blood-brain barrier genomics. II.Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections.Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5'-untranslated region.Vascular proteomics and subtractive antibody expression cloning.Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier.Blood-brain barrier genomics.Blood-brain barrier and new approaches to brain drug delivery.Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein.IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey.Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse.Blood-brain barrier biology and methodology.Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor.Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain.Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems.Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native proteinBrain-specific expression of an exogenous gene after i.v. administration.Blood-brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols.Blood-brain barrier drug targeting: the future of brain drug development.Molecular biology of the blood-brain barrier.Permeability changes in the blood-brain barrier: causes and consequences.Blood-brain barrier delivery.Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins.Human blood-brain barrier insulin-like growth factor receptor.Enhanced insulin binding to blood-brain barrier in vivo and to brain microvessels in vitro in newborn rabbits.Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate.Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.Insulin receptor antibody-sulfamidase fusion protein penetrates the primate blood-brain barrier and reduces glycosoaminoglycans in Sanfilippo type A cells.
P50
Q21092913-D5D9DFBD-FDAE-4E5A-A237-2F48F4CE5CC3Q22336985-06FD011A-54F0-495C-A61A-083AAE348402Q24672407-EC9C4C1A-FCAE-4CB3-9A50-961A9BE48E28Q28141750-F213A5DF-00AB-4C49-BD9A-FA074910098EQ28257034-39890274-064A-4E41-A423-C6942A1164CDQ28295704-C8EB9416-E042-465E-8A4F-2641E5DDC16BQ28305371-89281BF4-E047-4D8D-89C9-811675647A76Q30697700-8077BF69-4230-4E8A-98EA-BBABA27AC847Q30765797-A47B399B-907D-4B2F-8702-C03A0507DC8EQ30833003-3CAF368E-B7DA-430F-8DDE-17024AB4C80FQ30837654-6ADA27E2-34E3-4E55-8126-FA5F4301B02EQ30870836-3C4470B8-0226-47AB-A27F-CBF14F2A07EDQ30872658-A03DC410-B6F1-4763-9B83-C51891E2B083Q30885022-C987FCC9-EBC0-4B18-87BD-F1080D3926A4Q31092545-90171095-BD31-4C38-B198-87DEFE36438AQ32147231-BECDE5D7-130F-477D-9850-87004515D6A2Q33270802-0E0AF4C6-A18C-4D6C-AF2F-09554018A1B8Q33560065-5B1C3766-A969-48EE-9E0F-CE2BBB389807Q33703457-4261A8F4-FC88-4817-9BF5-1F8C4F00811EQ33726978-CDCA77E9-0155-4C1B-ACCE-3CC706A739D1Q33754804-E3D90817-7A48-457E-B126-E15669094780Q33797055-223E1CC1-CB3E-4EA1-8ED2-173EB64C3DE1Q33805709-EFFA2313-9915-4C6A-8DE9-0F06F2048DCBQ33827984-86E3F288-5A2C-4C3A-BA0C-3E1A4D6E7D71Q33851297-1DD1A3DE-88AF-429D-AC20-7C79D974FAC4Q33861126-1CC7AD17-8E5B-45E0-8DDA-860B8CFEAF80Q33864565-E7D66BCF-7151-4E50-8CE5-D3AA5BA241A0Q33948080-7C6744F9-3A66-4C8B-8E43-52DD8501DD8FQ33964235-14E7C394-44FA-4B76-9301-29259876EA03Q33976325-70125B8F-71E0-492E-9EA6-B8DD83B89878Q33986161-5317D522-3858-4450-9860-7D7F0E4350B3Q33999749-76B6007C-C6DC-449F-827B-02E9E4843D4CQ34001715-F57B4EC4-F26C-422D-A9EF-D8012CA75FB0Q34035426-687FABF9-5142-4744-8F3F-0B4DFCB0085CQ34048475-E3DC8F6E-366C-4696-8539-1664B95624BAQ34051026-D1134673-BB7C-404F-AB46-82271808215EQ34058435-7A4614B1-9107-4ED7-863E-5638518A6956Q34060172-6F64E8A5-F0D0-45EC-A908-8E9F2D6815D4Q34061528-635C0AA8-41A7-4071-9141-9115F3E18454Q34065044-A6841CBA-E79F-4DD4-BE9B-B014EA55FF8E
P50
description
physician, scientist and businessman; Distinguished Professor Emeritus at UCLA
@en
wetenschapper
@nl
name
William M Pardridge
@af
William M Pardridge
@an
William M Pardridge
@ast
William M Pardridge
@bar
William M Pardridge
@br
William M Pardridge
@ca
William M Pardridge
@co
William M Pardridge
@cs
William M Pardridge
@cy
William M Pardridge
@da
type
label
William M Pardridge
@af
William M Pardridge
@an
William M Pardridge
@ast
William M Pardridge
@bar
William M Pardridge
@br
William M Pardridge
@ca
William M Pardridge
@co
William M Pardridge
@cs
William M Pardridge
@cy
William M Pardridge
@da
altLabel
William Pardridge
@en
prefLabel
William M Pardridge
@af
William M Pardridge
@an
William M Pardridge
@ast
William M Pardridge
@bar
William M Pardridge
@br
William M Pardridge
@ca
William M Pardridge
@co
William M Pardridge
@cs
William M Pardridge
@cy
William M Pardridge
@da
P108
P1006
P214
P244
P1006
P106
P21
P213
0000 0000 2534 7482
P214
P244
P31
P496
0000-0002-2664-1338
P7859
lccn-n85304142